DBV Technologies submits BLA to FDA for VIASKIN Peanut Patch in ages 4—7, requests Priority Review

DBV Technologies submitted a Biologics License Application to the U.S. FDA for the VIASKIN Peanut Patch for children ages 4 through 7 and requested Priority Review.Key Highlights:Original SEC Filing: DBV Technologies S.A. [ DBVT ] - 8-K - Sep. 29, 2026This is an AI-powered summary. It may contain i…